BackReplimune Group Overview
Replimune Group Inc

Replimune Group Target Price

See Replimune Group's analyst price targets ($16) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.67

Average Target Price

$15.501.1% downside

6 analysts in the last 4 months

High: $20 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07BMO Capital$2027.6% upsideOpen
2026-08-07WedbushRobert Driscoll$1921.3% upsideOpen
2026-08-04Leerink PartnersDaina Graybosch$178.5% upsideOpen
2026-07-31WedbushRobert Driscoll$1223.4% downsideOpen
2026-06-30Wedbush$942.6% downsideOpen
2026-06-30BMO CapitalEvan Seigerman$162.1% upsideOpen
2026-02-05Piper Sandler$1410.7% downsideOpen
2025-11-03BMO CapitalEvan Seigerman$1129.8% downsideOpen
2025-10-27H.C. Wainwright$1223.4% downsideOpen
2025-10-20Wedbush$1814.9% upsideOpen
2025-01-22BMO CapitalEvan Seigerman$2772.3% upsideOpen
2024-12-03JefferiesRoger Song$1921.3% upsideOpen
2024-06-07H.C. WainwrightRobert Burns$178.5% upsideOpen
2024-06-04BarclaysPeter Lawson$1317% downsideOpen
2024-05-17BMO CapitalEvan Seigerman$1410.7% downsideOpen
2022-12-12BMO Capital$70346.7% upsideOpen
2022-12-07Leerink Partners$34117% upsideOpen
2022-10-03Leerink Partners$3091.4% upsideOpen
2022-08-17Piper Sandler$43174.4% upsideOpen
2022-08-05Leerink Partners$37136.1% upsideOpen
2022-05-20Leerink Partners$48206.3% upsideOpen

Replimune Group (REPL) FAQ

Replimune Group (REPL) currently reports a target price of $16. Use the charts on this page to explore Replimune Group's target price history and peer comparisons.

Analysts' average 12-month price target for Replimune Group is $16, about 1.1% downside from the current share price of $15.67. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $16, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Replimune Group, and consider following REPL for alerts when major investors trade the stock.

Replimune Group is classified in the Healthcare sector. On target price, it currently shows $16. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REPL with unrelated industries.